Ira Weinstein
Plus aucun poste en cours
Profil
Ira Weinstein served as the Chief Executive Officer at Hapto Biotech Ltd.
and InCure Ltd.
He also worked as the Chief Operating & Financial Officer at Keryx Biopharmaceuticals, Inc. and BioCancell Therapeutics, Inc. Weinstein received his undergraduate degree and MBA from Baruch College.
Anciens postes connus de Ira Weinstein
| Sociétés | Poste | Fin |
|---|---|---|
BioCancell Therapeutics, Inc.
 BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Directeur Financier/CFO | 20/06/2010 |
| KERYX BIOPHARMACEUTICALS | Directeur Financier/CFO | - |
InCure Ltd.
 InCure Ltd. Medical SpecialtiesHealth Technology InCure Ltd. is a start-up biotechnology company developing an early detection immunological kit of solid carcinoma invasion and metastasis. A critical event in malignant tumor development is the acquisition of the ability to invade through basement membranes and then reemerge from the blood vessels to establish new metastatic colonies at distant sites | President | - |
Hapto Biotech Ltd.
 Hapto Biotech Ltd. BiotechnologyHealth Technology Part of Forticell Bioscience, Inc., Hapto Biotech Ltd. develops and manufactures biological products for tissue repair and regeneration. The company is based in Jerusalem, Israel. Hapto Biotech was acquired by Forticell Bioscience, Inc. on April 17, 2006 for $9.41 million. | President | - |
Formation de Ira Weinstein
| Baruch College | Masters Business Admin |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 4 |
|---|---|
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Health Technology |
Hapto Biotech Ltd.
Hapto Biotech Ltd. BiotechnologyHealth Technology Part of Forticell Bioscience, Inc., Hapto Biotech Ltd. develops and manufactures biological products for tissue repair and regeneration. The company is based in Jerusalem, Israel. Hapto Biotech was acquired by Forticell Bioscience, Inc. on April 17, 2006 for $9.41 million. | Health Technology |
InCure Ltd.
InCure Ltd. Medical SpecialtiesHealth Technology InCure Ltd. is a start-up biotechnology company developing an early detection immunological kit of solid carcinoma invasion and metastasis. A critical event in malignant tumor development is the acquisition of the ability to invade through basement membranes and then reemerge from the blood vessels to establish new metastatic colonies at distant sites | Health Technology |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
